Summit Therapeutics Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Summit Therapeutics Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q3 2024.
  • Summit Therapeutics Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 737M shares, a 5.62% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 737M +39.2M +5.62% Sep 30, 2024 10-Q 2024-10-30
Q2 2024 724M +26.6M +3.82% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 702M +4.29M +0.62% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 702M +491M +232% Dec 31, 2023 10-Q 2024-10-30
Q3 2023 698M +497M +247% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 698M +600M +611% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 698M +600M +611% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 211M +113M +115% Dec 31, 2022 10-K 2024-02-20
Q3 2022 201M +104M +106% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 98.1M +771K +0.79% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 98.1M +15.2M +18.3% Mar 31, 2022 10-Q 2022-05-11
Q4 2021 98M +15.5M +18.7% Dec 31, 2021 10-K 2023-03-09
Q3 2021 97.6M +30.4M +45.2% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 97.4M +30.1M +44.8% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 82.9M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 82.6M +15.4M +22.9% Dec 31, 2020 10-K/A 2022-12-21
Q3 2020 67.2M Sep 30, 2020 10-Q 2020-11-16
Q2 2020 67.2M Jun 30, 2020 8-K 2020-09-29
Q4 2019 67.2M +35.1M +109% Dec 31, 2019 10-K 2021-03-31
Q4 2018 32.1M +17.4M +118% Jan 31, 2019 8-K 2020-09-29
Q4 2017 14.7M Jan 31, 2018 8-K 2020-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.